These findings support the notion that promoter hypomethylation contributes to the overexpression of key TGF-β signaling components during astrocytoma progression and may underlie their functional activation in the high-grade tumor microenvironment. This evidence concerns the gene TGFB1 and astrocytoma (excluding glioblastoma).